January 03, 2024 at 04:07PM CASGEVY

CASGEVY indicated for the treatment of sickle cell disease (SCD) in patients 12 years and older with recurrent vaso occlusive crises (VOCs).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XdJDS3v